Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Captor Capital Corp. C.CPTR

Captor Capital Corp. is a Canada-based investment firm focused on the cannabis sector. The Company's principal business activity is the retail sale of cannabis products. The Company has a retail license for selling of cannabis products in the state of California, United States. The Company's segments include Canada, United States, and Other. The Company provides recreational cannabis products to consumers, as well as other cannabis-based goods directly to California consumers through its retail locations and online and delivery networks. The Company has seven cannabis dispensaries, which operate under the proprietary name One Plant, located in Santa Cruz, Antioch, Salinas, Lompoc, Goleta, Atwater and Castroville (the Dispensaries). Supplementing the brick-and-mortar retail presence is the Company's direct to consumer delivery business, which also operates under the One Plant brand.


CSE:CPTR - Post by User

Bullboard Posts
Comment by realitycheck00on Apr 12, 2018 11:37am
98 Views
Post# 27873480

RE:One could surmise getting NWURF off the OTC and on the

RE:One could surmise getting NWURF off the OTC and on the Agreed IBHforlife as no one really knows about CPTR right now.  They need IR, PR and institutional coverage.  Once the MJ heard gets wind of the potential of CPTR then the sky is the limit.  The market would price in their current accomplishments and future potential into the stock price.

At $.80 to $1 this stock would still be trading at a multiple much less than any of its peer in the MJ space.  Getting to $2 to $3 could be achived by boosting acquisiitons and revenues to $60M to $80M per year and releasing some guidance on production capacities and potential revenues from all dispensaries including the new acquisitions.

Bullboard Posts